Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaso-occlusive Pain Episode in Sickle Cell Disease”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Testing effectiveness (Phase 2)Study completedNCT01796678
What this trial is testing

Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial

Who this might be right for
Vaso-occlusive Pain Episodes
UCSF Benioff Children's Hospital Oakland 56
Testing effectiveness (Phase 2)Study completedNCT05075824
What this trial is testing

A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD)

Who this might be right for
Sickle Cell Disease
Hoffmann-La Roche 95
Testing effectiveness (Phase 2)Looking for participantsNCT06635902
What this trial is testing

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseVaso-occlusive Pain Episode
Suvankar Majumdar 99
Early research (Phase 1)Study completedNCT04912869
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOE) in Participants With Sickle Cell Disease (SCD).

Who this might be right for
Sickle Cell Disease
Hoffmann-La Roche 30
Large-scale testing (Phase 3)Ended earlyNCT04150757
What this trial is testing

Intranasal Ketamine for Pain Control in Patients with Sickle Cell Disease and Vaso-occlusive Episode (VOE) in the PED

Who this might be right for
Sickle Cell DiseaseVaso-Occlusive Pain Episode in Sickle Cell DiseaseVaso-occlusive Crisis+3 more
Abigail Nixon 5
Not applicableLooking for participantsNCT06773715
What this trial is testing

Virtual Reality As Adjunct Therapy for Vaso-Occlusive Pain

Who this might be right for
Sickle Cell DiseaseVaso-occlusive Pain Episodes
Louisiana State University Health Sciences Center in New Orleans 36
Large-scale testing (Phase 3)Not Yet RecruitingNCT07274254
What this trial is testing

Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease

Who this might be right for
Vaso-Occlusive Pain Episode in Sickle Cell Disease
Nantes University Hospital 104
Post-approval studies (Phase 4)UnknownNCT05848531
What this trial is testing

Clonidine With Morphine in Patient Controlled Analgesia Pump in Vaso-Occlusive Crisis in Sickle Cell Disease Patient

Who this might be right for
Sickle Cell DiseaseVaso-occlusive Pain Episode in Sickle Cell Disease
Centre Hospitalier Universitaire Saint Pierre 40
Post-approval studies (Phase 4)Looking for participantsNCT06665997
What this trial is testing

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease (SCD)Vaso-Occlusive Pain Episode in Sickle Cell Disease
University of Pennsylvania 65
Testing effectiveness (Phase 2)Looking for participantsNCT07369024
What this trial is testing

Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults

Who this might be right for
Sickle Cell DiseaseVaso-Occlusive Pain Episode in Sickle Cell DiseaseKetamine Infusion+2 more
Mohsen Saidinejad 120
Testing effectiveness (Phase 2)Study completedNCT04987489
What this trial is testing

Etavopivat in Patients With Thalassemia or Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseThalassemia
Forma Therapeutics, Inc. 53
Large-scale testing (Phase 3)Ended earlyNCT04927247
What this trial is testing

A Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises

Who this might be right for
Sickle Cell DiseaseVaso-occlusive CrisisVaso-occlusive Pain Episode in Sickle Cell Disease
Pfizer 72
Large-scale testing (Phase 3)Study completedNCT04935879
What this trial is testing

Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises

Who this might be right for
Sickle Cell DiseaseVaso-occlusive Pain Episode in Sickle Cell DiseaseVaso-occlusive Crisis
Pfizer 241
Not applicableStudy completedNCT04584528
What this trial is testing

Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseGenetic DiseaseHematologic Diseases+1 more
Duke University 279
Not applicableLooking for participantsNCT06184126
What this trial is testing

Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises

Who this might be right for
Sickle Cell DiseaseVaso-occlusive Pain Episode in Sickle Cell DiseaseAcute Pain
University of Maryland, Baltimore 30
Large-scale testing (Phase 3)Ended earlyNCT05348915
What this trial is testing

Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseVaso-occlusive CrisisVaso-occlusive Pain Episode in Sickle Cell Disease
Pfizer 242